Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Inhaled colistin for treatment of pneumonia due to colistin-only-susceptible Acinetobacter baumannii.

Choi HK, Kim YK, Kim HY, Uh Y.

Yonsei Med J. 2014 Jan;55(1):118-25. doi: 10.3349/ymj.2014.55.1.118.

2.

Aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii pneumonia: experience in a tertiary care hospital in northern Taiwan.

Lin CC, Liu TC, Kuo CF, Liu CP, Lee CM.

J Microbiol Immunol Infect. 2010 Aug;43(4):323-31. doi: 10.1016/S1684-1182(10)60050-3.

3.

Use of high-dose IV and aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment?

Kalin G, Alp E, Coskun R, Demiraslan H, Gündogan K, Doganay M.

J Infect Chemother. 2012 Dec;18(6):872-7. doi: 10.1007/s10156-012-0430-7. Epub 2012 May 29.

PMID:
22644081
4.

Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.

Michalopoulos A, Kasiakou SK, Mastora Z, Rellos K, Kapaskelis AM, Falagas ME.

Crit Care. 2005 Feb;9(1):R53-9. Epub 2005 Jan 6.

5.

Outcome of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa treated with aerosolized colistin in neonates: a retrospective chart review.

Celik IH, Oguz SS, Demirel G, Erdeve O, Dilmen U.

Eur J Pediatr. 2012 Feb;171(2):311-6. doi: 10.1007/s00431-011-1537-z. Epub 2011 Aug 2.

PMID:
21809011
6.

Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.

Michalopoulos A, Fotakis D, Virtzili S, Vletsas C, Raftopoulou S, Mastora Z, Falagas ME.

Respir Med. 2008 Mar;102(3):407-12. Epub 2007 Dec 3.

7.

Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.

Arnold HM, Sawyer AM, Kollef MH.

Respir Care. 2012 Aug;57(8):1226-33. doi: 10.4187/respcare.01556. Epub 2012 Feb 17.

8.

Comparison of colistin and colistin/sulbactam for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia.

Kalin G, Alp E, Akin A, Coskun R, Doganay M.

Infection. 2014 Feb;42(1):37-42. doi: 10.1007/s15010-013-0495-y. Epub 2013 Jul 5.

PMID:
23828559
9.

Safety in treatment of ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii with aerosolized colistin in neonates: a preliminary report.

Nakwan N, Wannaro J, Thongmak T, Pornladnum P, Saksawad R, Nakwan N, Chokephaibulkit K.

Pediatr Pulmonol. 2011 Jan;46(1):60-6. doi: 10.1002/ppul.21324. Epub 2010 Sep 1.

PMID:
20812247
10.

Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible gram-negative bacteria.

Tumbarello M, De Pascale G, Trecarichi EM, De Martino S, Bello G, Maviglia R, Spanu T, Antonelli M.

Chest. 2013 Dec;144(6):1768-75. doi: 10.1378/chest.13-1018.

PMID:
23989805
11.

Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series.

Falagas ME, Siempos II, Rafailidis PI, Korbila IP, Ioannidou E, Michalopoulos A.

Respir Med. 2009 May;103(5):707-13. doi: 10.1016/j.rmed.2008.11.018. Epub 2008 Dec 31.

12.

[Aerosolized colistin in the treatment of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa pneunomia].

Peral Sánchez D, Armero Ibáñez R, Seller Losada JM, Solaz Roldán C.

Med Clin (Barc). 2007 Sep 22;129(10):397. Spanish. No abstract available.

PMID:
17915139
13.

Colistin inhalation monotherapy for ventilator-associated pneumonia of Acinetobacter baumannii in prematurity.

Kang CH, Tsai CM, Wu TH, Wu HY, Chung MY, Chen CC, Huang YC, Liu SF, Liao DL, Niu CK, Lee CH, Yu HR.

Pediatr Pulmonol. 2014 Apr;49(4):381-8. doi: 10.1002/ppul.22750. Epub 2013 Jan 28.

PMID:
23359527
15.

Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia.

Khawcharoenporn T, Pruetpongpun N, Tiamsak P, Rutchanawech S, Mundy LM, Apisarnthanarak A.

Int J Antimicrob Agents. 2014 Apr;43(4):378-82. doi: 10.1016/j.ijantimicag.2014.01.016. Epub 2014 Feb 14.

PMID:
24613422
16.

Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.

Kwa AL, Loh C, Low JG, Kurup A, Tam VH.

Clin Infect Dis. 2005 Sep 1;41(5):754-7. Epub 2005 Jul 20.

17.

Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.

Lu Q, Luo R, Bodin L, Yang J, Zahr N, Aubry A, Golmard JL, Rouby JJ; Nebulized Antibiotics Study Group.

Anesthesiology. 2012 Dec;117(6):1335-47. doi: 10.1097/ALN.0b013e31827515de.

PMID:
23132092
18.

Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii.

Motaouakkil S, Charra B, Hachimi A, Nejmi H, Benslama A, Elmdaghri N, Belabbes H, Benbachir M.

J Infect. 2006 Oct;53(4):274-8. Epub 2006 Jan 25.

PMID:
16442632
19.

Influencing factors of successful eradication of multidrug-resistant Acinetobacter baumannii in the respiratory tract with aerosolized colistin.

Chen YM, Fang WF, Kao HC, Chen HC, Tsai YC, Shen LS, Li CL, Chang HC, Huang KT, Lin MC, Wang CC, Chao TY.

Biomed J. 2014 Sep-Oct;37(5):314-20. doi: 10.4103/2319-4170.132879.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk